Bio

Kazuki Kusaka joined MTS Health Partners in December 2017 to build MTS’ practice in Japan. Mr. Kusaka is one of the most experienced healthcare bankers in Japan and has been in the industry for nearly 30 years ; he has been focusing on the healthcare space for more than 20 years. Mr. Kusaka has broad relationships with pharmaceutical, biotech, medical device and healthcare service companies in Japan. Prior to joining MTS, Mr. Kusaka led the healthcare practice for Lazard in Japan for 10 years providing M&A advisory services to Japanese healthcare companies with a major focus on cross-border M&A transactions. Prior to Lazard, Mr. Kusaka was a Managing Director and the head of Asia Healthcare Group at Lehman Brothers from 2000 to 2007. Mr. Kusaka founded the group in 2000 and provided M&A advisory and equity/debt financing services to healthcare companies in major countries in Asia including Japan, Korea, China and Singapore. Mr. Kusaka also worked for UBS in Japan as the Head of the Japan Healthcare Group. Selected transactions include the merger of Fujisawa and Yamanouchi to create Astellas, Sumitomo Dainippon Pharma’s acquisition of Tolero, Miraca’s acquisition of Caris and Hisamitsu’s acquisition of Noven. Mr. Kusaka started his banking career as an investment banking analyst at Kidder, Peabody in 1990. Mr. Kusaka graduated from Tokyo University with BA in Psychology.